Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingqiao antiviral granules
- Development stage
- Unknown
- Lead developer
- Hospital of Chengdu University of Traditional Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Qingqiao antiviral granules is a Traditional Chinese Medicine (TCM) hospital preparation developed by the Hospital of Chengdu University of Traditional Chinese Medicine (CDUTCM). Formulated based on classical TCM principles for clearing heat and detoxifying (Qingre Jiedu), it was specifically designed to treat viral respiratory infections, including influenza and COVID-19. During the COVID-19 pandemic, the preparation was approved by the Sichuan Provincial Medical Products Administration as a hospital preparation for use in designated medical institutions within Sichuan Province. It is intended to alleviate symptoms such as fever, cough, and sore throat by inhibiting viral replication and modulating the host's inflammatory response.
- Brand names
- Qingqiao antiviral granules
- Other names
- Qingqiao Kangdu Keli清翘抗毒颗粒
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))Mpro (3C-like proteinase of SARS-CoV-2)IL-6 (Interleukin 6)
Beyond the preview
Go deeper on Qingqiao antiviral granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qingqiao antiviral granules.